CA
NZ
UK
AU
IND
US
To appreciate why this matters, it helps to understand what makes continuous blood glucose monitoring, or CBGM, technically difficult in the first place. Most glucose monitors on the market today are worn externally or use short-term subcutaneous sensors that need regular replacement. Glucotrack is …
Understanding why this combination makes clinical sense requires understanding what each drug does individually. PADCEV is an antibody-drug conjugate, a therapy that combines a targeting antibody with a potent cytotoxic payload, designed to deliver cancer-killing chemotherapy directly and specifically to tumor cells expressing a …
The specific findings center on three interconnected pharmacological properties: oral bioavailability, systemic exposure, and tissue distribution. Oral bioavailability measures how much of an orally administered drug actually reaches systemic circulation intact, a critical practical consideration since a drug that can't be reliably absorbed through …
It's worth understanding why this stage of development carries real weight even without an accompanying efficacy readout. Dose-escalation enrollment is the process of methodically enrolling patients across a range of drug doses to establish safety, tolerability, and an appropriate dose for further study. Completing …
The SALT score quantifies the percentage of scalp hair loss, meaning a mean reduction of this magnitude translates into visible, measurable hair regrowth for trial participants, not just a marginal or cosmetic effect. Layered on top of that headline figure, the trial also reported …
The transaction involved approximately 619,965 common shares or pre-funded warrants, a relatively modest share count on its face. But the real story sits in what came attached to that raise: newly issued Series A-3 and Series A-4 warrants, each exercisable at $6.21 per share. …
On paper, this should have been an unambiguously positive day for the stock. Rating upgrades paired with substantial price target increases typically move shares higher, sometimes sharply, as institutional investors and algorithmic screens react to the bullish signal. A jump from $3 to $13 …
The $1.00 minimum bid price rule is one of Nasdaq's core continued-listing standards, designed to ensure that companies trading on the exchange maintain a share price reflecting a baseline level of market confidence and liquidity. Companies that fall below this threshold for an extended …
Q32 Bio (NASDAQ: QTTB) posted Phase 2a SIGNAL-AA Part B results for bempikibart in severe alopecia areata, showing a 35.3% mean reduction in SALT scores in the mITT population and a 40% SALT-20 response rate. With no new safety signals emerging, the company said …
The facts are straightforward: BL1107, also known as WB007, did not meet its primary endpoint in a Phase 2 glaucoma study. Rather than pursuing additional post-hoc analyses in search of a salvageable subgroup signal, or committing further resources to a program that failed its …
Please wait processing your request...